(20) Liraglutide was dosed at 1.2mg/d, and low-calorie substitutions were permitted for both the control and study group as needed for weight maintenance
We used multiple rigorous methods (including propensity score matching) to achieve a well-balanced analytic cohort of more than 18,000 patients to appropriately evaluate the effectiveness of semaglutide compared with tirzepatide for weight loss
Conservatively, GLP-1 medications are already removing over $3.3 billion a year from the Canadian food economymostly from snacks, baked goods, sugary beverages, and alcohol
This can trigger unexpected grief in researchers whose relationship with food was deeply tied to comfort, social connection, or identity
Individual results vary significantly, and these numbers come from supervised clinical settings with lifestyle counseling
EMA statement on ongoing review of GLP-1 receptor agonists Internet Document